Advertisement Banner
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
No Result
View All Result
HealthNews
No Result
View All Result
Home Medicine

Single Oral Dose of Azithromycin Cuts Risk of Postpartum Sepsis, Death

February 13, 2023
in Medicine

Source Link: https://www.medicalbag.com/home/news/nih-single-oral-dose-of-azithromycin-cuts-risk-of-postpartum-sepsis-death/


A single oral dose of azithromycin was found to significantly lower the risk of maternal sepsis or death among women planning a vaginal delivery, according to new data published in The New England Journal of Medicine.

The National Institutes of Health (NIH)-led phase 3 study (A-PLUS; ClinicalTrials.gov Identifier: NCT03871491) included 29,278 women who were in labor at 28 weeks’ gestation or more and who were planning a vaginal delivery. Between September 2020 and August 2022, study participants were randomly assigned to receive either a single 2g oral dose of azithromycin or placebo during labor. The primary endpoints of the study were the incidence of maternal death or sepsis, as well as the incidence of intrapartum/neonatal death or sepsis. 

Within the first 6 weeks after delivery, the incidence of maternal sepsis or death was 1.6% in the azithromycin arm compared with 2.4% in the placebo arm, with a relative risk of 0.67 (95% CI, 0.56-0.79; P <.001). Findings showed the maternal primary outcome was mainly driven by the difference in the incidence of sepsis between the azithromycin and placebo arms (1.5% vs 2.3%, respectively), with a relative risk of 0.65 (95% CI, 0.55-0.77).


Continue Reading

While treatment with azithromycin significantly lowered the risk of maternal sepsis or death compared with placebo, the analysis demonstrated little effect on neonatal death or sepsis (10.5% vs 10.3%), with a relative risk of 1.02 (95% CI, 0.95-1.09; P =.56).

The study was originally designed to enroll up to 34,000 women. However, during an interim analysis, the trial was stopped early due to the clear maternal benefit based on a recommendation from the data and safety monitoring committee.

“These findings have the potential to change clinical practice by providing a safe, effective and low-cost approach to reduce the global burden of maternal sepsis and death,” said Diana W. Bianchi, MD, director of NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the primary funder of the trial. “We urgently need effective strategies to prevent pregnancy-related infections, which account for roughly 10% of maternal deaths worldwide.”

References

  1. Single-dose antibiotic prevents maternal sepsis and death. News release. National Institutes of Health. Accessed February 9, 2023. https://www.nih.gov/news-events/news-releases/single-dose-antibiotic-prevents-maternal-sepsis-death.
  2. Tita AT, Carlo WA, McClure EM, et al. Azithromycin to prevent sepsis or death in women planning a vaginal birth. N Engl J Med. Published online February 9, 2023. doi:10.1056/NEJMoa2212111

This article originally appeared on MPR



Source link

Advertisement Banner
Previous Post

MediBuddy buys Aetna’s telehealth biz in India

Next Post

Expert Shares Theory About Potential Cause

Next Post

Expert Shares Theory About Potential Cause

Discussion about this post

Recommended

Data confirm vaccine-drug combo ‘drastically’ reduces malaria

3 months ago

Clinical Challenge: Sudden Onset of Vomiting and Sweating

3 months ago

Don't Miss

Why Does National Security Depend on Forever Chemicals?

December 6, 2023

Endoluminal robotics company EndoQuest scores $42M

December 6, 2023

Gen AI speeds up workflows, drug development, Health News, ET HealthWorld

December 6, 2023

Struggling With Stress? Consider Avoiding Fatty Food For Better Recovery

December 6, 2023

© Pharma News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Medicine
  • Health Tech
  • Health Tech
  • Health Living
  • Contact
  • Privacy Policy

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact

© 2022 Pharma News Hubb All rights reserved.